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SMYD3�� a �istone met�yltransferase�� was first 
found upregulated in �uman colorectal cancer �CRC�� 
and �epatocellular carcinoma �HCC�� [�]. Its over-
expression promotes cell proliferation particularly in 
tumors�� indicating t�at SMYD3 may play an important 
role in carcinogenesis [�]. Recently�� Tsuge et al. [�] 
reported a variable number of t�e tandem repeats 
�VNTR�� polymorp�ism CCGCC in t�e 5ʹ flanking re-
gion of SMYD3�� w�ic� is a binding site of E�F-�. T�e 
E�F-�-binding affinity is �ig�er to t�ree repeats and 
results in an increased promoter activity compared 
wit� t�e two repeats. Furt�ermore�� t�e t�ree repeats 
�ave been identified as a �ig�-risk allele associated 
wit� CRC�� HCC�� and breast cancer in a Japanese 
population [�]. However�� t�e results from ot�er study 
were not consistent. For example�� t�e association of 
�/� polymorp�ism of SMYD3 could not be found wit� 
bot� familial breast cancer and �ig�-risk familial breast 
cancer cases [�]. Genetic disorders are complex to 
certain diseases�� particularly for cancer�� and genetic 
susceptibility to disease may vary among populations 
due to allele differences in bot� frequencies and com-
position as illustrated by t�e recent data generated by 
t�e Hap�ap project [4]. To investigate t�e potential 
association between t�e functional SMYD3 tandem 
repeats polymorp�ism and HCC in t�e C�inese popu-
lation�� we conducted t�is case-control study among 
��� HCCs and �6� �ealt�y controls. 
Subjects and samples. T�is study included 
��� HCC patients and �6� �ealt�y controls. All sub-
jects were genetically unrelated et�nic Han C�inese. 
Patients wit� HCC were newly diagnosed based on 
pat�ological analyses and classified according to t�e 
tumor-node-metastasis classification [5] at Queen 
�ary Hospital�� Hong Kong. Population controls were 
partially from �ealt�y blood donors randomly col-
lected from Red Cross of Hong Kong and partially 
from �ealt�y individuals in t�e same period as t�e HCC 
cases were collected and most of t�em were enrolled 
in ot�er previous studies of our department [6]. T�e 
study was approved by t�e local Institutional Review 
Board. �ean age �± SD�� and gender proportion in 
eac� group were as follows: HCC�� 54.44 ± ��.8��� 
and 8�.5% male; controls�� 44.�� ± ��.���� and 5�.�% 
male. Of t�e HCC patients�� 85% were �epatitis B virus 
positive w�ereas 6% were �epatitis C virus positive. 
Among t�e ��� HCC patients�� t�e distribution of tu-
mor-node-metastasis stage I�� II�� II�� and IV were ��%�� 
�6%�� ��.5%�� and �.5%�� respectively. Genomic DNA 
was extracted from t�e perip�eral blood leukocytes 
using t�e QIAamp blood kit �Qiagen�� Valencia�� CA�� 
according to t�e manufacturer’s instructions.
VNTR polymorphism of SMDY3. T�e VNTR poly-
morp�ism in t�e promoter of SMDY3 was genotyped 
by PCR and direct-sequencing analysis. Primers used 
for PCR VNTR DNA fragments were t�e same as de-
scribed previously [�]. T�e resulting PCR fragments 
were t�en subjected to DNA sequencing analysis by an 
ABI ���� genetic analyzer �Applied Biosystems�� Foster 
City�� CA�� using t�e BigDye Terminator �v�.���.
Statistical analysis. T�e association between t�e 
polymorp�isms and risk of HCC was estimated using 
odds ratio and its �5% confidence interval�� w�ic� 
were calculated by unconditional logistic regression 
and adjusted for age and gender. All analyses were 
performed wit� Statistical Analysis System software 
�version 6.��; SAS Institute�� Cary�� NC��.
T�e distribution of t�e VNTR polymorp�ism of 
SMYD3 in t�is study is listed in Table �. T�e allele 
frequencies for SMYD3 � repeats and � repeats were 
�5.��% and 84.��% among t�e �6� controls; and 
��.�5%�� and 8�.�5% among t�e ��� HCC cases. 
T�ese differences were not statistically significant 
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�P = �.����. T�e frequency of �/� genotype was �5.5% 
in HCC group and 6�.�% in control group. T�e odds 
ratio of �/� genotype compared wit� �/� or �/� geno-
type was �.�� ��5% confidence interval�� �.8���.�6���� 
w�ic� was not statistically significant �P = �.�8��. From 
bot� allele and repeat frequencies of SMYD3�� t�ere 
was no significant difference between control and 
HCC group. Furt�ermore�� we analyzed t�e correla-
tion between t�e SMYD3 genotype and metastasis 
of HCC �Table ����� but t�e distributions of SMYD3 �/� 
genotype among different stages of HCC were similar 
���.5%�� ��.�%�� and �4.�% in stages I�� II�� and III + IV�� 
respectively; Pfor trend = �.45��.
Table	1. SMYD3 po�ymorp�ism and HCC ris�
SMYD3 Contro�s (n = 261) Cases (n = 200) Odds ratio (95% CI) P va��en (%) n (%)
2/2 2 (0.8) 2 (1.0) 1.002/3 78 (29.9) 47 (23.5)
3/3 181 (69.3) 151 (75.5) 1.30 (0.81–2.06) 0.180
2 a��e�e 82 (15.71) 51 (12.75) 1
3 a��e�e 440 (84.29) 349 (87.25) 1.28 (0.86–1.89) 0.220
Table	2. SMYD3 �enotype and a��e�e fre��encies amon� patients �it� 
different t�mor sta�es
St�dy �ro�p Tota� s�bjects 2/2 or 2/3 3/3
a
No (%) No (%) No (%)
T�mor-node-metastasis-sta�e
I 78 (39.0) 16 (20.5) 62 (79.5)
II 52 (26.0) 15 (28.8) 37 (71.2)
III + IV 70 (35.0) 18 (25.7) 52 (74.3)
aP for trend  = 0.450.
VNTR polymorp�ism of SMYD3 �as been firstly 
reported to be a susceptibility factor in several �uman 
cancers including HCC in t�e Japanese population 
[�]. However�� t�e results from ot�er study were not 
consistent. �ost recently�� Frank et al. [�] did not found 
t�e association of �/� polymorp�ism of SMYD3 wit� 
bot� familial breast cancer and �ig�-risk familial breast 
cancer cases. T�e present study revealed t�at t�ere 
were no statistically significant differences of SMYD3 
VNTR polymorp�ism in allele and genotype frequen-
cies between HCC patients and �ealt�y controls. In 
addition�� we did not find any correlations between t�e 
SMYD3 polymorp�ism and different stages of HCC 
disease. T�ese results indicated t�at SMYD3 VNTR 
polymorp�ism is not associated wit� HCC in terms of 
HCC risk and disease development.
We’d like to notice t�at our data are controversial to 
t�оse of Japanese group [�]. One of t�e possibilities 
is t�at differences of a genetic polymorp�ism as a risk 
factor in two populations may be affected by various 
gene-environment interactions during cancer develop-
ment. For example�� geograp�ical differences in HCC 
incidence partially reflect variations of viral infection 
[�]. In Japan�� �epatitis C virus-associated HCC inci-
dence is ��%�� w�ereas �epatitis B virus ���%�� is t�e 
major cause of liver c�ronic infection leading to HCC in 
Sout� Asia including Hong Kong [�]. In our study�� 85% 
of t�e HCC patients were �epatitis B virus positive and 
only 6% were �epatitis C virus positive. T�erefore�� it 
would be of interest to investigate w�et�er t�e role of 
SYMD3 polymorp�ism in carcinogenesis is dependent 
on t�e type of viral infection in HCC.
In conclusion�� t�ere was found no association of 
SMYD3 tandem repeats polymorp�ism wit� HCC oc-
currence and metastasis in t�e C�inese population. 
T�is is t�e first null report in HCC and more indepen-
dent studies mig�t be needed to verify t�e association 
between t�is polymorp�ism and cancer in different 
populations.
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Отсутствие связи между пОлимОрфизмОм 
тандемных пОвтОрОв SMYD3 и вОзникнОвением 
и метастазирОванием карцинОмы печени 
у населения китая 
Известно, что полиморфизм тандемных повторов (VNTR) в ре��л�торном �част�е �ена     SMYD3, �одир�ющем метилтрансфераз� 
�истонов, ассоциирован с развитием ра�а пр�мой �иш�и, �арциномы печени (HCC)ира�амолочной�елезыи�вл�етс�поп�л�цион-       
но-зависимой хара�теристи�ой. Цель работы состо�ла в исследовании возмо�ной св�зи ме�д� VNTR �еном  SMYD3 и развитием 
HCC � населени� Кита�. Материалы и методы: исследование типа “сл�чай-�онтроль” проводили с �частием 200 пациентов с 
HCC и 261 здорово�о донора. �олиморфизм VNTR в промоторной области �ена           SMDY3 �енотипировали методами PCR и пр�мо�о   
се�венировани�. Дл� оцен�и св�зи ме�д� полиморфизмом и рис�ом развити� HCC использовали отношение шансов (OR) и 95%       
доверительные интервалы. Результаты: частота аллелей дл� повторов SMYD3 2 и 3 составила 15,71 и 84,29% в �онтрольной 
�р�ппе и 12,75 и 87,25% — в �р�ппе больных (P = 0,22). OR �енотипов 3/3   versus 2/2 и 2/3 составило 1,30 (P = 0.18). Частота 
3 аллелей не возрастала при повышении стадии заболевани� (P = 0,45). Выводы: полиморфизм �ена SMYD3 не ассоциирован 
с развитием и метастазированием HCC � населени� Кита�.   
Ключевые слова: SMDY3, полиморфизм, �арцинома печени.
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